Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...

We recently compiled a list of the Top 10 Health Insurance Stocks To Buy. In this article, we are going to take a look at ...

Health insurers, including Cigna, Humana and Elevance Health, are tucking changes to DEI strategies and business risks into ...

Artisan Partners, an investment management company, released its “Artisan Select Equity Fund” fourth quarter 2024 investor ...

Elevance Health (ELV) shares soared 3.1% in the last trading session to close at $422.04. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

If you'd like to see what analysts are forecasting going forward, you should check out our free analyst report for Elevance Health . What Can We Tell From Elevance Health's ROCE Trend? While the ...

I published my first article on Elevance Health immediately following the third quarter earnings report, and from the feedback I've received, I realize that I may have come across as too ...

See if the 14 Elevance Health analysts we track are forecasting continued growth with our free report on analyst estimates for the company. If you are a dividend investor, you might also want to ...

We came across a bullish thesis on Elevance Health, Inc. (NYSE:ELV) on ValueInvestorsClub by rhubarb. In this article, we ...

“They continue to report, year-over-year ... it will continue using data-driven insights to simplify health care. Yet Elevance is subject to pressures far beyond Wall Street.